Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Referring Patients with Colorectal Cancer to Clinical Trials

July 12th 2016

Role of TAS-102 (Trifluridine/tipiracil) in Advanced Colorectal Cancer

July 12th 2016

Colorectal Cancer: Regorafenib Patient Selection and Dosing

July 12th 2016

Goals of Therapy in Refractory Colorectal Cancer

July 12th 2016

Decisions in Colorectal Cancer Maintenance Therapy and Sequencing

July 12th 2016

Right- Versus Left-Sided Colorectal Tumors and Survival

July 12th 2016

Colorectal Cancer: Choosing a Biologic

July 12th 2016

Neoadjuvant and Adjuvant Therapy in Metastatic Colorectal Cancer

July 12th 2016

Goals of Systemic Therapy in Colorectal Cancer

July 12th 2016

Multidisciplinary Approaches in Metastatic Colorectal Cancer

July 12th 2016

Optimizing Care in Metastatic Colorectal Cancer

July 12th 2016

Finding Actionable Biomarkers in Colorectal Cancer

July 12th 2016

Liquid- Vs Tissue-Based Testing in Colorectal Cancer

July 12th 2016

An Update on Molecular Testing in Colorectal Cancer

July 12th 2016

Putting in Longer Hours for World-Class Care

July 11th 2016

Ventura County Hematology Oncology Specialists opened its doors 45 years ago and has long occupied a comfortable niche in its local market.

Chasing the Holy Grail of EHR Interoperability

July 8th 2016

COTA Inc, an independent health care informatics company was founded to build research-grade, real-world data to exponentially improve outcomes and reduce costs—ensuring the right care for the right patient every time.

FDA Releases Draft Guidances on Next-Generation Sequencing

July 7th 2016

The FDA has issued two draft guidances that will provide regulatory oversight for the use of next-generation sequencing-based tests.

Ibrutinib Granted Breakthrough Designation for Chronic GVHD

June 30th 2016

The FDA has granted a breakthrough therapy designation to ibrutinib has a potential treatment for patients with chronic graft-versus-host-disease after failure of one or more lines of systemic therapy.

CMS Announces Practices Participating in OCM and Launch Date

June 30th 2016

A year after announcing its intention to launch the Oncology Care Model alternative payment plan for oncology care, The Centers for Medicare & Medicaid Services said it has 196 practices enrolled across the United States and that the official start date is Friday, July 1.

Pazdur Named Head of New Oncology Center of Excellence

June 30th 2016

Richard Pazdur, MD, has been named the acting director of the FDA's newly created Oncology Center of Excellence, which is aimed to expedite the development of novel combination products and support an integrated approach to oncology research.